About
SutroVax, now renamed Vaxcyte, is a biotechnology company developing next-generation conjugate vaccines targeting bacterial infectious diseases such as pneumococcal disease, Group A Streptococcus, and Shigella.
Explore SutroVax's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.